Insider Selling: Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Insider Sells 35,000 Shares of Stock

Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB – Get Free Report) insider Thomas Gad sold 35,000 shares of the firm’s stock in a transaction that occurred on Monday, June 10th. The shares were sold at an average price of $12.03, for a total transaction of $421,050.00. Following the completion of the sale, the insider now directly owns 197,681 […]

Related Keywords

United States ,China , ,Y Mabs Therapeutics Company Profile ,Ameritas Investment Partners Inc ,Sg Americas Securities ,Securities Exchange Commission ,Bailard Inc ,Nasdaq ,Tower Research Capital ,Y Mabs Therapeutics Inc ,China Universal Asset Management Co ,Canaccord Genuity Group ,Y Mabs Therapeutics ,Get Free Report ,Thomas Gad ,Exchange Commission ,Abs Therapeutics ,Genuity Group ,Universal Asset Management ,Research Capital ,Investment Partners ,Y Mabs Therapeutics Daily ,